Victor Tapson, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism (NCT03988842) | Victor Tapson, MD | 2019-07-25 |
Track Victor Tapson, MD automatically
Every clearance here is in the API, with alerts when new ones post.